Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Effectiveness of digital therapy approaches in prevention, rehabilitation and rehabilitation aftercare].

Orthopadie (Heidelberg, Germany)·2026

Same author

Inhibition of miR-21: cardioprotective effects in human failing myocardium ex vivo.

European heart journal·2024

Same author

The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activity.

Matrix biology : journal of the International Society for Matrix Biology·2024

Same author

Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension.

Scientific reports·2024

Same author

Encapsulating In Vitro Transcribed circRNA into Lipid Nanoparticles Via Microfluidic Mixing.

Methods in molecular biology (Clifton, N.J.)·2024

Same author

A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: May 25, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

Epigenetic modifications in cardiovascular disease.

Johan M Lorenzen¹, Filippo Martino, Thomas Thum

¹Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany. J.M.Lorenzen@gmail.com

Basic Research in Cardiology

|January 12, 2012

Summary

This summary is machine-generated.

Epigenetic modifications, like DNA methylation, influence gene expression without altering DNA sequence. These changes are increasingly linked to cardiovascular disease development and progression.

Related Experiment Videos

Last Updated: May 25, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

Area of Science:

Molecular Biology
Genetics
Cardiovascular Science

Background:

Epigenetics involves heritable changes in gene expression without DNA sequence alteration.
Epigenetic mechanisms, including DNA methylation, histone modifications, and RNA-based regulation, control crucial cellular processes.
Exogenous factors can influence epigenetic modifications, potentially leading to disease, including cardiovascular conditions.

Purpose of the Study:

To review recent research on epigenetic modifications in cardiovascular disease.
To highlight the role of DNA methylation, histone modifications, and RNA-based mechanisms in cardiovascular pathology.

Main Methods:

Literature review of recent studies on epigenetics and cardiovascular disease.
Analysis of mechanisms including DNA methylation, histone modifications, and non-coding RNAs.

Main Results:

Abnormal DNA methylation of CpG islands can silence genes, impacting biological function.
Histone modifications alter DNA accessibility, modulating gene expression.
RNA-based mechanisms, such as microRNAs and long non-coding RNAs, play a role in disease development.

Conclusions:

Epigenetic alterations are implicated in the pathogenesis of cardiovascular disease.
Understanding these epigenetic changes is crucial for developing new therapeutic strategies for cardiovascular conditions.